Efficacy of Digital Breast Tomosynthesis + Standard 2- Dimensional Mammography in Breast Cancer
Completed · Not applicable
Conditions studied: Breast Cancer
In brief
The purpose of this study is to determine if a 3-dimensional mammogram (DBT) may provide additional information to evaluate the extent of disease and additional findings that would aid in staging a new breast cancer patient. This would impact surgical planning and improve patient outcomes.
Key facts
- Study ID
- NCT03190083
- Run by
- Case Comprehensive Cancer Center
- People needed
- 16
- Starts
- 2017-07-01
- Expected to finish
- 2018-06-13
- Last updated by the study team
- 2022-06-27
Who can join
Age: 25 and older, up to 85. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- New diagnosis of breast cancer
- New diagnosis if a previous breast cancer patient with negative surgical margins
- Patients willing to sign a written informed consent form
You may not qualify if…
- High risk benign lesions as the primary pathology diagnosis
Where it is running
- Cleveland Clinic, Case Comprehensive Cancer Center — Cleveland, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.